Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jun;12(2):176-81.
doi: 10.3904/kjim.1997.12.2.176.

Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjögren's syndrome

C S Cho  1 , S H Park, J K Min, S H Lee, H Y Kim
Affiliations

Clinical significances of antibodies to Ro/SS-A autoantigens and its subtypes in primary Sjögren's syndrome

C S Cho et al. Korean J Intern Med. 1997 Jun.

Abstract

Objective: To evaluate the patterns of Ro autoantigen recognition in Korean patients with primary Sjögren's syndrome (SS) and to investigate its clinical significance in SS.

Methods: Sera from primary SS (n = 51) and systemic lupus erythematosus (SLE) (n = 132) were tested by double immunodiffusion test and immunoblotting for reactivity with 60 kDa and 52 kDa Ro/SS-A proteins. Clinical manifestations were evaluated on the basis of the presence of anti-Ro/SS-A antibodies and anti-60 kDa/52 kDa proteins.

Results: The prevalence of anti-Ro/SS-A antibodies in Korean patients with primary SS was 64.7%. In immunoblotting analysis, the incidence of anti-60 kDa without anti-52 kDa was lower in patients with SS(3.0% vs. 11.6%, p > 0.05), whereas anti-52 kDa without anti-60 kDa was more common in SS patients than in SLE patients(42.5% vs. 4.3%, p < 0.001). Patients with anti-Ro/SS-A antibody were significantly associated with the presence of vasculitis, hyperglobulinemia and rheumatoid factor in primary SS (p < 0.05).

Conclusion: The patterns of 52 kDa and 60 kDa Ro autoantigen recognition were quite different in the SLE and primary SS. Anti-52 kDa without anti-60 kDa antibody may be used as a diagnostic marker for primary SS. Although the presence of anti-Ro/SS-A antibody was closely associated with certain clinical features in SS, these clinical manifestations were not correlated with the presence of antibodies against each 52 kDa and 60 kDa proteins. Extended studies with a large population are required to determine the clinical correlation of autoantibodies against each peptides or epitopes of Ro/SS-A proteins.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Comparision of the clinical manifestations in anti-Ro positive versus anti-Ro negative primary SS. *p<0.05
Fig. 2.
Fig. 2.
Comparison of clinical manifestations in anti-Ro positive primary SS patients with anti-60kDa/52kDa antibody versus those with only anti-52kDa antibody.
See this image and copyright information in PMC

References

    1. Barakar S, Meyer O, Torterotot F, Youinou P, Briand JP, Kahn MF. IgG antibodies from patients with primary Sjogren’s syndrome and systemic lupus erythematosus recognize diffemetepitopes in 60-kD SS-A/Ro protein. Clin Exp Immunol. 1992;89:38–45. - PMC - PubMed
    1. Chan EKL, Tan EM. Epitopic targets for autoantibodies in systemic lupus erythematosus and Sjogren syndrome. Curr Op Rheumatol. 1980;1:376–381. - PubMed
    1. Meilof JF. Autoantibodies against small cytoplasmic ribonucleoproteins: the anti-Ro/SS-A and anti-La/SS-B autoimmune response. Rheumatol Int. 1992;12:129–140. - PubMed
    1. Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune responses to the SS-A(Ro) 52-kd and 60-kd polypetides in systemic lupus erythematosus and Sjogren’s syndrome. Arthritis Rheum. 1990;33:349–355. - PubMed
    1. Meilof JF, Bantjes I, De Jong J, Van Dam AP, Smeenk RJT. The detection of anti-Ro/SS-A and anti-Ro/SS-A and anti-La/SS-B antibodies. J Immunol Methods. 1990;133:215–226. - PubMed